| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/03/1993 | EP0525252A1 Use of staphylokinase for the preparation of a pharmaceutical composition for treating arterial thrombosis |
| 02/03/1993 | EP0525163A1 Binding of growth hormone to liposomes. |
| 02/03/1993 | EP0525158A1 Hyperglycemic compositions |
| 02/03/1993 | EP0525119A1 Antibody conjugates for treatment of neoplastic disease |
| 02/03/1993 | EP0525076A1 Recombinant bile salt activated lipases |
| 02/03/1993 | EP0525054A1 Modified heparin binding growth factors |
| 02/03/1993 | EP0386076B1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 02/03/1993 | EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof |
| 02/03/1993 | EP0346343B1 Anti-viral therapeutic composition |
| 02/03/1993 | CN1068501A A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 02/02/1993 | US5183884 Novel proteins (erbB-3 gene) of the erB proto-oncogene family; immunoassay; antitumor and -carcinogenic agents |
| 02/02/1993 | US5183814 Selective oestrogen therapy for perimenopausal or postmenopausal conditions |
| 02/02/1993 | US5183809 Cyclodextrin polymers and cyclodextrins immobilized on a solid surface |
| 02/02/1993 | US5183805 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/02/1993 | US5183804 Anticarcinogenic agents |
| 02/02/1993 | US5183802 Mixed with nontoxic effective amount of adsorption enhancer-ammonium glycyrrhizinate and a carrier; used as nose sprays for treatment of osteoporosis |
| 02/02/1993 | US5183756 Produced by a hybridoma assigned A.T.C.C.Accession No.HB 9796; which does not bind with other cancer or normal human tissue; useful for diagnosis and evolution of disease |
| 02/02/1993 | US5183746 Formulation processes for pharmaceutical compositions of recombinant β- |
| 02/02/1993 | US5183657 Antibodies for use in antilymphocyte antibody therapy |
| 02/02/1993 | US5183462 Standardizing dosage of denervating agent by injecting into muscle, determining extent of inhibition of acetylcholine release |
| 02/02/1993 | CA2075163A1 A87689 compounds |
| 02/02/1993 | CA2075005A1 Water-soluble composition for sustained-release |
| 02/02/1993 | CA1313371C Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation |
| 02/01/1993 | CA2074662A1 Anti-idiotypic antibodies that mimic tnf |
| 01/31/1993 | CA2074967A1 Hexapeptide |
| 01/28/1993 | DE4224213A1 Hirudinanaloge und verfahren zu ihrer herstellung Hirudinanaloge and processes for their preparation |
| 01/28/1993 | DE4223282A1 Zubereitung zur stetigen und kontrollierten abgabe von medikamentoesen substanzen und verfahren zu deren herstellung Preparation for continuous and controlled release of medicamentous substances and processes for their preparation |
| 01/28/1993 | DE4143214A1 Synergistisch wirkende antikoerperzusammensetzung Synergistic antikoerperzusammensetzung |
| 01/28/1993 | DE4124758A1 Antitumorwirksame substanz aus humanen makrophagen Effective antitumor substance from human macrophages |
| 01/28/1993 | DE4124503A1 Compsn. for inducing puberty and synchronising oestrus in young sows - contains PGF2 alpha or its analogue, esp. cloprostenol providing improved litter size |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524834A2 Immunosuppressive drugs containing a cysteine protease |
| 01/27/1993 | EP0524803A2 Thromboplastin extract, reagent, and preparation thereof |
| 01/27/1993 | EP0524796A1 Use of essential fatty acids in the preparation of a medicament for the treatment of AIDS |
| 01/27/1993 | EP0524768A2 Ribotoxins, conjugates thereof ans pharmaceutical composition |
| 01/27/1993 | EP0524737A2 Protein s. polypeptides and anti-peptide antibodies that inhibit protein s binding TO C4b binding protein, diagnostic systems and therapeutic methods |
| 01/27/1993 | EP0524732A2 Composition containing lactic acid bacteria for preventing dental caries |
| 01/27/1993 | EP0524681A1 Process for the purification of serum albumin |
| 01/27/1993 | EP0524553A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 01/27/1993 | EP0524421A1 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/27/1993 | EP0524360A1 A somatotropin-based improved process for the farming of salmonids, particularly in seawater |
| 01/27/1993 | EP0524260A1 GPIb$g(a) FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
| 01/27/1993 | EP0409940A4 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 01/27/1993 | CN1068334A Peptides useful in regulating immune and nervous systems |
| 01/27/1993 | CN1068333A Pharmacologically active hydrazine derivatives and processes for preparation thereof |
| 01/26/1993 | US5182368 Lymphokines, antibodies |
| 01/26/1993 | US5182364 Polypeptide analogs of apolipoprotein E |
| 01/26/1993 | US5182302 Method for enhancing growth of mammary parenchyma using a prostaglandin |
| 01/26/1993 | US5182293 Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones |
| 01/26/1993 | US5182285 Cell-protective composition for preventing or treating of peptic ulcer |
| 01/26/1993 | US5182266 Method for treating renal disease |
| 01/26/1993 | US5182265 Pharmacologically active peptide derivatives and pharmaceutical preparations containing them |
| 01/26/1993 | US5182264 Angiotensin II receptor blockers as antiglaucoma agents |
| 01/26/1993 | US5182263 Analogs of tyrosine sulfate or tyrosine phosphate containing peptides |
| 01/26/1993 | US5182262 Polypeptides which mediate immune responses and may be useful in preventing organ transplant rejection |
| 01/26/1993 | US5182261 Modified transforming growth factor alpha oligopeptides and pharmaceutical compositions thereof |
| 01/26/1993 | US5182260 Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them |
| 01/26/1993 | US5182259 Antithrombin and a viscoelastic material |
| 01/26/1993 | US5182258 Systemic delivery of polypeptides through the eye |
| 01/26/1993 | US5182257 Anticarcinogenic agents |
| 01/26/1993 | US5182196 Expression systems for overproduction of desired proteins |
| 01/26/1993 | US5182192 Diagnosis of adenocarcinoma |
| 01/26/1993 | US5182113 Factor xa inibitor from leech and pharmaceutical compositions containing same |
| 01/26/1993 | US5182111 In vivo delivery of active factors by co-cultured cell implants |
| 01/26/1993 | US5182107 Delivering nerve growth factor across blood brain barrier to brain |
| 01/26/1993 | US5182106 Method for treating hypothermia |
| 01/26/1993 | CA2074626A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |
| 01/26/1993 | CA1313157C Gastrin releasing peptide antagonist |
| 01/26/1993 | CA1313134C Endogenous growth hormone |
| 01/26/1993 | CA1313131C Forms for application of -interferons |
| 01/25/1993 | CA2073913A1 Preparation of fatty acid medicaments |
| 01/25/1993 | CA2070751A1 Proteins |
| 01/23/1993 | CA2074394A1 Somatotropin-based improved process for the farming of salmonids, particularly in seawater |
| 01/21/1993 | WO1993001303A1 Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
| 01/21/1993 | WO1993001302A1 Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
| 01/21/1993 | WO1993001301A1 Mutant antiviral regulatory proteins |
| 01/21/1993 | WO1993001300A1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 01/21/1993 | WO1993001291A1 Herpes virus proteinase and method of assaying |
| 01/21/1993 | WO1993001289A1 Humanized interleukin-2 receptors antibodies |
| 01/21/1993 | WO1993001281A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 01/21/1993 | WO1993001275A1 NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
| 01/21/1993 | WO1993001215A1 Pla2 inhibitory compounds |
| 01/21/1993 | WO1993001214A1 Recombinant human interleukin 6 with homogeneous n-terminus and production thereof |
| 01/21/1993 | WO1993001213A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/21/1993 | WO1993001211A1 Peptide which abrogates tnf and/or lps toxicity |
| 01/21/1993 | WO1993001209A1 Proteins s polypeptides and uses thereof |
| 01/21/1993 | WO1993001208A1 2-[3-(4-amidinophenyl)]propionic acid derivatives, their preparation and their use |
| 01/21/1993 | WO1993001207A1 Process for the purification of serum albumin |
| 01/21/1993 | WO1993001205A1 Tyrosine kinase |
| 01/21/1993 | WO1993001169A2 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993001167A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
| 01/21/1993 | WO1993001165A2 Aromatic compounds, compositions containing them and their use in therapy |
| 01/21/1993 | WO1993001160A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993001159A1 Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993000948A1 Syringe system |
| 01/21/1993 | WO1993000935A1 Implant materials |
| 01/21/1993 | WO1993000926A1 Treatment of periodontal disease with protease inhibitors |
| 01/21/1993 | WO1993000924A1 Use of lipases to produce drugs |
| 01/21/1993 | WO1993000923A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | WO1993000922A1 Peptides aiding nerve regeneration |